Get to know Michigan Anesthesiology's three new faculty members

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

In this episode of Minding Memory, Matt & Donovan speak with Dr. Lisa Barnes, the Alla V. and Solomon Jesmer Professor of Gerontology and Geriatric Medicine, Department of Neurological Sciences and Associate-Director of the Rush Alzheimer’s Disease Center at Rush University. Dr. Barnes talks with Matt & Donovan about racial disparities in Alzheimer’s disease dementia and several obstacles that have impeded our understanding of race and dementia.

It showed high levels of accuracy at predicting death, major bleeding events and the need for blood transfusion. Visit Health Lab to read the full story. The BMC2 Probability of Events Following PCI application can be found here.

Researchers at Michigan Medicine developed an AI-driven algorithm that accurately predicts death and complications after PCI — which could emerge as a tool for clinicians as they determine treatment for blocked heart arteries.

George Mashour, MD, PhD at the University of Michigan Department of Anesthesiology featured on the StarTalk Podcast.

Buying health care services directly online offers convenience but also risks if patients don’t tell their regular doctor or provider. Poll looks at older adults’ use and attitudes.

Michael Burns, MD, PhD, in the U-M Department of Anesthesiology publishes Detroit News opinion piece on the role of anesthesiologists in integrating artificial intelligence into healthcare.

Researchers and clinicians at the U-M Health Frankel Cardiovascular Center began sending reconditioned pacemakers to low- and middle-income countries for compassionate use cases in 2010 through the “My Heart Your Heart” program.

A recent study from U-M offers more insight into the underlying causes of EOE.

A lack of regulation around CBD, Delta-8 and other cannabinoids could open up consumers to harm. Visit Health Lab to read the full story.A lack of regulation around CBD, Delta-8 and other cannabinoids could open up consumers to harm.